Radiotherapy - Reviews in Urology

All articles from this key word are listed below.

Volume 2, Supplement 4 Supplement

Perineal Prostatectomy, X-Rays, Protons, Neutrons, and Combination Brachytherapy

Therapeutic Strategies for Localized Prostate Cancer II:

Michael J Harris Douglas Chinn David C Beyer Arthur T Porter Michael D Weil Peter S Albert

Prostatic neoplasms Radiotherapy Survival analysis

Volume 4, Number 3 Point-Counterpoint

Selecting Treatment for High-Risk, Localized Prostate Cancer: The Case for Radiation Therapy

Robert Meier Michael K Brawer

Prostate cancer Radical prostatectomy Gleason score Radiotherapy Brachytherapy Biochemical disease-free outcome

Volume 4, Number 2 Point-Counterpoint

Radiation Therapy After Radical Prostatectomy: Why Patience Is a Virtue! The Case for Salvage Radiation Therapy

Kevin M Slawin

Prostate cancer Prostate-specific antigen Radiotherapy Prostatic fossa biopsy

Volume 4, Number 2 Point-Counterpoint

Radiation Therapy After Radical Prostatectomy: Strike Early, Strike Hard! The Case for Adjuvant Radiation Therapy

Dov Kadmon

Prostate cancer Radiotherapy Prostatectomy Positive surgical margins

Volume 5, Supplement 3 Supplement

Neoadjuvant Therapy for Prostate Cancer: An Oncologist's Perspective

Maha HA Hussain Elizabeth C Kent

Prostate cancer Chemotherapy Radical prostatectomy Radiotherapy Hormonal therapy Neoadjuvant therapy

Volume 5, Number 2 Meeting Reviews

Advances in Prostate Cancer Treatment

Highlights from the 2nd International Prostate Cancer Congress, St. Thomas, U.S. Virgin Islands

Alan W Partin Matthew B Gretzer

Prostate-specific antigen Nomograms Radiotherapy Hormone-refractory prostate cancer Radioimmunoscintigraphy Androgen blockade

Volume 6, Supplement 8 Supplement

Neoadjuvant Hormonal Therapy in Men Being Treated With Radiotherapy for Localized Prostate Cancer

Mack Roach III

Prostate cancer Radiotherapy External beam radiotherapy Randomized trials Neoadjuvant hormonaltherapy

Volume 6, Supplement 2 Supplement

Success and Failure of Single-Modality Treatment for Early Prostate Cancer

David G McLeod

Radical prostatectomy Radiotherapy Adjuvant hormonal therapy

Volume 8, Supplement 1 Review Articles

Fused Radioimmunoscintigraphy for Treatment Planning

Prostate Cancer Imaging

Deborah A Kaminsky Rodney J Ellis

Advances in imaging technologies, including computerized tomography (CT) and single-photon emission tomography (SPECT), are improving the role of imaging in prostate cancer diagnosis and treatment. Hybrid (SPECT/CT) imaging, in particular, shows an increased sensitivity for identification of prostate cancer. Published studies have also recently proposed a new paradigm in the administration of radiation therapy for prostate cancer, favoring doseescalation strategies to improve tumor control for localized disease. Conventional dose-escalation protocols have previously relied primarily on margin extension to the entire prostate gland to achieve dose-escalation; extending increased risk to radiosensitive normal structures. A newer strategy proposes use of advanced imaging to confine dose-escalation to biological target volumes identified on capromab pendetide SPECT/CT-fused image sets or imageguided radiation therapy (IGRT). This strategy defines a shift in radiation dosimetry and planning from uniform glandular prescription dosing with doseescalation applied generically to the peripheral regions and margin extension; to dose-escalation confinement to discrete regions of known disease as defined by focal uptake on radioimmunoscintigraphy fusion with anatomic image sets, with minimal margin extension. The introduction of advanced imaging for IGRT in prostate cancer has also introduced an improved capability for the early-identification of patients at risk for metastatic disease, where more aggressive therapeutic interventions may prove beneficial. [Rev Urol. 2006;8(suppl 1):S11-S19]

Prostate cancer Radiotherapy Brachytherapy ProstaScint SPECT/CT Biological targetvolumes Survival

Main Content

Top Content

Therapeutic Strategies for Localized Prostate Cancer II:

Highlights from the 2nd International Prostate Cancer Congress, St. Thomas, U.S. Virgin Islands

Prostate Cancer Imaging